Unlocking the Mysteries of Consciousness: SIDHE Announces Revolutionary Research Pathways and Transformative Programs

2 months ago

Unlocking the Mysteries of Consciousness: SIDHE Institute Launches Groundbreaking Research and Transformative Programs Merging Ancient Wisdom with Modern Science to…

Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer

2 months ago

Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settingsVANCOUVER, British…

The International Myeloma Foundation Welcomes Four Newly Elected Members to the IMF Board of Directors

2 months ago

Extends Gratitude to Outgoing Board Members for Their Years of Dedicated Service to the IMF BoardSTUDIO CITY, Calif., Nov. 26,…

Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders

2 months ago

MIAMI, FL, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System

2 months ago

Contract Unlocks Significant Market Opportunities Across Federal Healthcare SystemsROSELAND, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:…

Gelteq Announces 400,000 Units Enter into Production in November 2024

2 months ago

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based…

CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products

2 months ago

BERKELEY HEIGHTS, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment

2 months ago

Trial results demonstrated safety and effectiveness of FemaSeed intratubal insemination with high satisfaction ratings from both practitioners and patientsATLANTA, Nov.…

Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

2 months ago

PDUFA target action date extended by three months to March 27, 2025REDWOOD CITY, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) --…

Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results

2 months ago

Intelligent Fingerprinting Drug Screening System on path to FDA 510(k) submission, expected in the fourth calendar quarter of 2024 INBS…